B7 (protein)

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

It has been suggested that CD80 be merged into this article or section. (Discuss)

It has been suggested that CD86 be merged into this article or section. (Discuss)

B7 is a type of peripheral membrane protein found on activated antigen presenting cells (APC) that, when paired with either a CD28 or CD152 (CTLA-4) surface protein on a T cell, can produce a costimulatory signal to enhance the activity of a MHC-TCR signal between the APC and the T cell. (Coico et al. 2003)

There are two major types of B7 proteins, B7.1 and B7.2 or CD80 and CD86 respectively, however it is not known if they differ significantly.

Costimulation

There are several steps to activation of the immune system against a foreign molecule. The T cell receptor must first interact with the MHC molecule. This first interaction involves the CD4 or CD8 proteins which form a complex with the CD3 protein to bind to the MHC molecule of the APC. However, this is insufficient for producing a T cell response by itself. In fact, lack of further stimulatory signals sends the T cell into anergy. The costimulatory signal necessary to continue the immune response can come from B7-CD28 and CD40-CD40L interactions. There are other activation signals which play a role in immune responses. In the TNF family of molecules, the protein 4-1BB (CD137) on the T cell may bind to 4-1BBL on the APC.

The primary role of the B7 proteins is to give a second signal to the T cell. The B7 protein is present on the APC and is able to interact with the CD28 receptor on the T cell surface. This interaction produces a series of downstream signals which continue the cell's response. Blockade of CD28 is effective in stopping T cell activation. The immune system takes advantage of this detail to stop immune responses. The T cell can express CTLA-4 (CD152) on its surface as well. CTLA-4 is similar to the CD28 but has 20x greater affinity for B7 proteins. However, it does not stimulate the T cell despite binding well to this receptor. As a result, the T cell is blocked from receiving the B7 protein signal and is not activated. Instead it receives an inhibitory signal which leads to downregulation of the immune response. As an illustration, mice with disrupted CTLA-4 genes are unable to stop immune responses and develop a fatal massive lymphocyte proliferation.

References

• Coico, R., Sunshine, G., and Benjamin, E. (2003). “Immunology: A Short Course 5th ed.” Pg. 131.
• Janeway, CA, Travers P, Walport M, Shlomchik MJ. (2001). "Immunobiology." 5th ed. ISBN 0-8153-3642-X.

WikiDoc Help Menu Quick Start.. Get Started Here! How to Login How to Search Pages How to Start a New Page How to Edit a Page Cheat Sheet Editing basics Learning Basic Formatting How to make Links in WikiDoc & to External Sites How to Make Lists How to Ignoring Formatting Adding References or Footnotes to Articles Tracking Changes You Have Made How to Put an Article Into a Category When Multiple Topics Should Go To The Same Page (MI, Acute MI, AMI) Using Redirection Advanced editing How to Make Tables How to Insert Images and Other Media How to Add Video Help:How to Make Columns Web Colors How To Make Templates How to Move Pages Inserting Dynamic Dates and Times Inserting WikiDoc Statistics Editing the Table of Contents Communicating your edits Let others know what you changed: The importance of Edit Summaries Minor Edits Edit Conflicts Help Videos You Can Watch Getting Started Video

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .